These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1191708)

  • 21. Biosynthesis of immunoglobulin in human immunoproliferative diseases. I. Kinetics of synthesis and secretion of immunoglobulin and protein by bone marrow cells in myeloma.
    Hammerton K; Cooper DA; Duckett M; Penny R
    J Immunol; 1978 Aug; 121(2):409-17. PubMed ID: 681741
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction of B-chain-inactivated ricin into mouse macrophages and rat Kupffer cells via their membrane Fc receptors.
    Refsnes K; Munthe-Kaas AC
    J Exp Med; 1976 Jun; 143(6):1464-74. PubMed ID: 1271014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of Tetrahymena to ricin, a toxic enzyme from Ricinus communis.
    Wilde CG; Boguslawski S; Houston LL
    Biochem Biophys Res Commun; 1979 Dec; 91(3):1082-8. PubMed ID: 118750
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of abrin and ricin on mammalian cells in tissue culture.
    Cheng MH; Lin JY; Kao WY; Jou TC; Tsai T
    Taiwan Yi Xue Hui Za Zhi; 1975 Apr; 74(4):236-43. PubMed ID: 1059722
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.
    Youle RJ; Neville DM
    J Biol Chem; 1982 Feb; 257(4):1598-601. PubMed ID: 6120167
    [No Abstract]   [Full Text] [Related]  

  • 26. The cytotoxic effects of abrin and ricin on Ehrlich ascites tumor cells.
    Lin JY; Chang YC; Huang LY; Tung TC
    Toxicon; 1973 Jul; 11(4):379-81. PubMed ID: 4751114
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of in vitro protein synthesis in a rabbit reticulocyte cell-free system by toxic trypsic peptides from ricin.
    Lugnier AA; Le Meur MA; Gerlinger P; Dirheimer G
    Biochimie; 1974; 56(9):1287-9. PubMed ID: 4451677
    [No Abstract]   [Full Text] [Related]  

  • 28. Homology between ricin and Ricinus communis agglutinin: amino terminal sequence analysis and protein synthesis inhibition studies.
    Cawley DB; Hedblom ML; Houston LL
    Arch Biochem Biophys; 1978 Oct; 190(2):744-55. PubMed ID: 718174
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition by ricin of protein synthesis in vitro. Ribosomes as the target of the toxin.
    Montanaro L; Sperti S; Stirpe F
    Biochem J; 1973 Nov; 136(3):677-83. PubMed ID: 4780693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells].
    Tonevitskiĭ AG
    Mol Biol (Mosk); 1985; 19(4):1034-41. PubMed ID: 4047033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding, uptake and degradation of the toxic proteins abrin and ricin by toxin-resistant cell variants.
    Sandvig K; Olsnes S; Pihl A
    Eur J Biochem; 1978 Jan; 82(1):13-23. PubMed ID: 620666
    [No Abstract]   [Full Text] [Related]  

  • 32. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
    Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the role of the covalent carbohydrate in the action of ricin.
    Simeral LS; Kapmeyer W; MacConnell WP; Kaplan NO
    J Biol Chem; 1980 Dec; 255(23):11098-101. PubMed ID: 6254960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro.
    Mahony J; Bose A; Cowdrey D; Nusair T; Lei M; Harris J; Marks A; Baumal R
    J Immunol; 1981 Jan; 126(1):113-7. PubMed ID: 7451962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of toxic radio-iodinated ricin for use in ricin-ribosome interaction studies.
    Lugnier AA
    FEBS Lett; 1976 Aug; 67(1):80-4. PubMed ID: 955107
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell surface receptors and their dynamics on toxin-treated malignant cells.
    Nicolson GL; Robbins JC; Hyman R
    J Supramol Struct; 1976; 4(1):15-26. PubMed ID: 1256060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of two mouse L cell lines resistant to the toxic lectin ricin.
    Gottlieb C; Kornfeld S
    J Biol Chem; 1976 Dec; 251(24):7761-8. PubMed ID: 1002711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of Ricin using 4-azidophenyl-beta-D-galactopyranoside and 4-diazophenyl-beta-D-galactopyranoside.
    Houston LL
    J Biol Chem; 1983 Jun; 258(11):7208-12. PubMed ID: 6853515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pharmacology of plant lectins: studies on ricin and concanavalin A (NSC-143504).
    Grollman AP; Grunfeld C; Brewer CF; Marcus DM
    Cancer Chemother Rep; 1974; 58(4):491-501. PubMed ID: 4859418
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of ricin toxin family members from Ricinus communis.
    Leshin J; Danielsen M; Credle JJ; Weeks A; O'Connell KP; Dretchen K
    Toxicon; 2010; 55(2-3):658-61. PubMed ID: 19781564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.